Sulfur Hexafluoride clinical trials
Also written Lumason and SonoVue.
Includes 14 studies of Contrast agent BR1.
How each study uses Sulfur Hexafluoride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Sulfur Hexafluoride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 10 Oct 2014 · LUMASON · NDA 203684 (FDA, Drugs@FDA)
- European Union
- 26 Mar 2001 · SonoVue · EMEA/H/C/000303 (EMA; as contrast agent BR1)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
51 studies that test it; most in 2020 (7); 1 more planned to start later
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 44
Bracco Diagnostics, Inc (7) · Children's Hospital of Philadelphia (6) · Mayo Clinic (3) · David Mooney (2) · Indiana University (2) · UNC Lineberger Comprehensive Cancer Center (2) · Milton S. Hershey Medical Center (2) · Boston Children's Hospital (2)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 8, 1 in phase 3
Studies that test Sulfur Hexafluoride, phase 3 first.
- Dec 2026A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsPhase 3 · NaviFUS Corporation
- Nov 2026Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast MassesPhase 1 · University of Southern California
- Dec 2026The Use of Contrast Enhanced Ultrasound (CEUS) In Post-Surgical Pancreatic Cancer Patients to Evaluate Local Disease RecurrenceNot applicable · Thomas Jefferson University
- Dec 2026CEUS for Blunt Abdominal Trauma in ChildrenPhase 4 · Children's Hospital of Philadelphia
- Apr 2027Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDHEarly Phase 1 · Children's Hospital of Philadelphia
- Jul 2027Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver TumorsPhase 2 · john eisenbrey
- Aug 2027Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post AblationPhase 2 · john eisenbrey
- Sep 2027CEUS Evaluation of Hydrocephalus in Neonates and InfantsPhase 2 · Children's Hospital of Philadelphia
Studies
Open first, then newest update. How each study uses Sulfur Hexafluoride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 52
- CEUS Evaluation of Hydrocephalus in Neonates and InfantsRecruitingPhase 2Children's Hospital of PhiladelphiaNCT06693752Written as Sulfur Hexafluoride Lipid Type A Microspheres 25 mg Injection Powder for Suspension [LUMASON]
- The Use of Contrast Enhanced Ultrasound (CEUS) In Post-Surgical Pancreatic Cancer Patients to Evaluate Local Disease RecurrenceRecruitingNot applicableThomas Jefferson UniversityNCT07910383Written as Lumason
- Lumason® Infusion vs. Bolus AdministrationsRecruitingPhase 3Bracco Diagnostics, IncNCT06400004Written as Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
- Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)Not yet recruitingPhase 1Boston Children's HospitalNCT03653702Written as Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
- Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDHRecruitingEarly Phase 1Children's Hospital of PhiladelphiaNCT03107520Written as Lumason
- A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsRecruitingPhase 3NaviFUS CorporationNCT06496971Written as Microbubble
- Study of Placental Vascularization Using Contrast UltrasoundRecruitingPhase 3Central Hospital, Nancy, FranceNCT06497959Written as SonoVue
- Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post AblationRecruitingPhase 2john eisenbreyNCT05641935Written as Sulfur Hexafluoride Lipid Microspheres
- Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver TumorsRecruitingPhase 2john eisenbreyNCT06261814Written as Sulfur Hexafluoride Lipid Microspheres
- Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast MassesRecruitingPhase 1University of Southern CaliforniaNCT06171607Written as Sulfur Hexafluoride Lipid Microspheres
- Liver Cirrhosis Complicated by Clinically Significant Portal HypertensionNot yet recruitingNot applicableFondazione Policlinico Universitario Agostino Gemelli IRCCSNCT07365709Written as SonoVue
- Neonatal Brain Ultrasound With CEUS and ElastographyRecruitingPhase 3Turku University HospitalNCT05648812Written as Sulfur Hexafluoride
- CEUS for Blunt Abdominal Trauma in ChildrenRecruitingPhase 4Children's Hospital of PhiladelphiaNCT03490929Written as Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON]
- Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHDCompletedPhase 1/2Nemours Children's ClinicNCT05186415Written as Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
- Preterm Neonates Brain Ultrasound With CEUS and ElastographyWithdrawnPhase 3Turku University HospitalNCT05694611Written as Sulfur Hexafluoride
- Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).WithdrawnEarly Phase 1Milton S. Hershey Medical CenterNCT05957042Written as Lumason
- Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study)CompletedPhase 1/2David MooneyNCT04718441Written as Lumason
- CEUS Evaluation of Hypoxic Ischemic InjuryCompletedPhase 3Children's Hospital of PhiladelphiaNCT03549520Written as Sulfur hexafluoride lipid-type A microspheres
- CEUS Evaluation of Bowel Perfusion in Necrotizing EnterocolitisTerminatedPhase 3Children's Hospital of PhiladelphiaNCT03549507Written as Sulfur hexafluoride lipid-type A microspheres
- BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ InjuryCompletedPhase 4Emory UniversityNCT05025449Written as Bubble-Enhanced FAST (BEFAST)
See all 52 studies that test Sulfur Hexafluoride →
Given beside what is tested · 8 — Sulfur Hexafluoride is usual care or a partner of the new treatment
- NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain TumorsRecruitingPhase 1Children's National Research InstituteNCT07664176Written as Lumason
- Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent GlioblastomaNot yet recruitingNot applicableUniversity of CincinnatiNCT07274787Written as Lumason
- Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and TauNot yet recruitingPhase 1Columbia UniversityNCT06600880Written as Lumason
- Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)SuspendedPhase 1/2NaviFUS CorporationNCT06329570Written as Lumason
- Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung DisordersTerminatedEarly Phase 1Thunder Bay Regional Health Research InstituteNCT02748798Written as SF6
- Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal AdenocarcinomaCompletedPhase 2St. Olavs HospitalNCT04146441Written as SonoVue
- Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal CancerCompletedPhase 1/2St. Olavs HospitalNCT03477019Written as SonoVue
- Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 RadioembolizationWithdrawnNot applicableUniversity of Southern CaliforniaNCT03300401Written as Sulfur Hexafluoride Lipid Microspheres
As the comparator · 1 — what is tested is compared with Sulfur Hexafluoride
What changed recently
From the registry's own updates since Oct 20, 2026.
Newly registered1
Codes
What other systems call Sulfur Hexafluoride · ClinicalTrials.gg INT008258
- MeSH (NLM) D013459Sulfur HexafluorideConfirmed NLM, Wikidata
- UNII (FDA) WS7LR3I1D6SULFUR HEXAFLUORIDEConfirmed FDA, NLM, Wikidata
- RxNorm 1599276Confirmed FDA, Wikidata
- Wikidata Q279055sulfur hexafluorideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C84187Sulfur HexafluorideOne source FDA
- DrugBank DB11104One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013459 | Sulfur Hexafluoride | Confirmed NLM, Wikidata |
| UNII (FDA) | WS7LR3I1D6 | SULFUR HEXAFLUORIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1599276 | — | Confirmed FDA, Wikidata |
| Wikidata | Q279055 | sulfur hexafluoride | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C84187 | Sulfur Hexafluoride | One source FDA |
| DrugBank | DB11104 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.